Finance

Lists
000623:SHE
Jilin Aodong Pharmaceutical Group Co Ltd
CNÂ¥17.38
+0.64%
(+0.11) 1D
Nov 4, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000623...
Open
CNÂ¥17.28
High
CNÂ¥17.47
Low
CNÂ¥17.18
Mkt. cap
20.65B
Avg. vol.
8.82M
Volume
16.92M
Dividend
2.88%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Oct 23, 2026
P/E ratio
6.81
52-wk high
CNÂ¥21.59
52-wk low
CNÂ¥16.36
EPS
CNÂ¥2.55
Shares outstanding
1.20B
No. of employees
5K
Open
CNÂ¥17.28
High
CNÂ¥17.47
Low
CNÂ¥17.18
Mkt. cap
20.65B
Avg. vol.
8.82M
Volume
16.92M
Dividend
2.88%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Oct 23, 2026
P/E ratio
6.81
52-wk high
CNÂ¥21.59
52-wk low
CNÂ¥16.36
EPS
CNÂ¥2.55
Shares outstanding
1.20B
No. of employees
5K
News stories
From web sources and news partners
Profile
Jilin Aodong Medicine Industry Group Company Limited is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business. It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996. Wikipedia
About Jilin Aodong Pharmaceutical Group Co Ltd
CEO-
Employees5.05K
FoundedMar 20, 1993
Headquarters-
SectorPharmaceutical industry
Industry-
Websitejlaod.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
694.88M
514.09M
516.91M
512.28M
Cost of goods sold
401.66M
265.19M
285.23M
267.25M
Cost of revenue
401.66M
265.19M
285.23M
267.25M
Research and development expenses
50.31M
14.36M
14.41M
21.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
375.32M
194.13M
204.97M
205.81M
Operating expense
462.78M
225.97M
230.21M
214.01M
Total operating expenses
864.44M
491.16M
515.45M
481.25M
Operating income
-169.57M
22.94M
1.46M
31.03M
Other non operating income
-11.31M
-653.65K
1.59M
-6.55M
EBT including unusual items
76.89M
865.54M
1.14B
818.40M
EBT excluding unusual items
310.73M
905.90M
1.31B
835.52M
Income tax expense
-29.05M
446.06K
-39.10M
11.29M
Effective tax rate
-37.77%
0.05%
-3.42%
1.38%
Other operating expenses
38.39M
10.48M
10.49M
-10.82M
Net income
134.74M
866.00M
1.18B
807.81M
Net profit margin
19.39%
168.45%
229.06%
157.69%
Earnings per share
-
-
-
-
Interest and investment income
507.32M
898.86M
1.31B
826.86M
Interest expense
-15.71M
-15.25M
-6.62M
-15.82M
Net interest expenses
491.61M
883.61M
1.31B
811.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-121.80M
70.71M
44.84M
78.79M
Gain or loss from assets sale
-1.32M
-
4.80M
-4.80M
Upcoming events
AI content may include mistakes. Learn more
Google apps